Seeking Alpha "Forget Amarin: BUY CLSN For A Bigger Score" ((((( link )))))
Forget Amarin: Buy Celsion For A Bigger Score
December 10, 2012 By: Alex Heisenberg
Between larger potential market, much cheaper valuation, insider buying, lack of competition, better balance sheet, and better potential of a short squeeze, my money is on CLSN. Forget AMRN. The big score will be with CLSN.
CLSN had a real nice run but is near it's top. Going to be dead money for awhile IMO. Read the article last night and again this morning and neither time did it make any sense. Sell AMRN to buy CLSN? Really? Dump a stock with an FDA-approved drug with a potentially huge patient base in favor of an company that has maybe a 40% chance of approval for a drug that has a TINY market at best? Don't think so.
This is such a huge risk compared to Amarin... what idiot who is risk averse (in Biotech - so it's a relative term) would do something so stupid? Now talk about a place where you really could lose all your money this is one...